Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors
1. Boye, K. S. et al. Utilities and disutilities for attributes of injectable treatments for type 2 diabetes. Eur. J. Heal. Econ. 12, 219–230 (2011). Article Google Scholar 2. Pratley,…

